Tearsheet

Kewaunee Scientific (KEQU)

Market Price (12/28/2025): $38.45 | Market Cap: $110.2 Mil
Sector: Consumer Discretionary | Industry: Household Appliances

Kewaunee Scientific (KEQU)

Market Price (12/28/2025): $38.45
Market Cap: $110.2 Mil
Sector: Consumer Discretionary
Industry: Household Appliances

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 11%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 6.6%	Key risks KEQU key risks include [1] a dependence on the volatile laboratory and healthcare construction industry and [2] a reliance on sole or limited-source suppliers for key materials.
1	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 43%
2	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -40%
3	Megatrend and thematic drivers Megatrends include Biotechnology & Genomics, and Precision Medicine. Themes include Gene Editing & Therapy, Advanced Diagnostics, Show more.

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 11%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 6.6%
1	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 43%
2	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -40%
3	Megatrend and thematic drivers Megatrends include Biotechnology & Genomics, and Precision Medicine. Themes include Gene Editing & Therapy, Advanced Diagnostics, Show more.
4	Key risks KEQU key risks include [1] a dependence on the volatile laboratory and healthcare construction industry and [2] a reliance on sole or limited-source suppliers for key materials.

Valuation, Metrics & Events

	12/28/25	2024	2023	2022
Share Price CYE	$38.45	$61.87	$29.07	$15.95
Market Cap CYE ($ Mil)	110.2	177.7	84.4	45.1
Total Debt ($ Mil)	46.7	50.2	11.0	12.9
Total Cash ($ Mil)	12.6	14.9	23.3	8.1
Enterprise Value ($ Mil)	144.3	227.9	95.4	58.0
Valuation Ratios
P/S TTM	0.4	0.7	0.4	0.2
P/EBIT TTM	5.5	9.8	5.6	7.2
P/E TTM	9.4	15.5	4.5	61.0
P/FCF TTM	21.5	14.0	5.5	-5.7
Sector Ratios
P/S TTM (Sector)	0.8	0.8	0.9	0.8
P/EBIT TTM (Sector)	7.8	8.3	7.8	6.5
P/E TTM (Sector)	10.5	11.1	10.4	8.4
P/FCF TTM (Sector)	11.2	12.4	9.6	7.3

	12/28/25	2024	2023
Share Price CYE	$38.45	$61.87	$29.07
Market Cap CYE ($ Mil)	110.2	177.7	84.4
Total Debt ($ Mil)	46.7	50.2	11.0
Total Cash ($ Mil)	12.6	14.9	23.3
Enterprise Value ($ Mil)	144.3	227.9	95.4
Valuation Ratios
P/S TTM	0.4	0.7	0.4
P/EBIT TTM	5.5	9.8	5.6
P/E TTM	9.4	15.5	4.5
P/FCF TTM	21.5	14.0	5.5
Sector Ratios
P/S TTM (Sector)	0.8	0.8	0.9
P/EBIT TTM (Sector)	7.8	8.3	7.8
P/E TTM (Sector)	10.5	11.1	10.4
P/FCF TTM (Sector)	11.2	12.4	9.6

	KEQU	S&P 500
REVENUE GROWTH	VERY GOOD
Rev LTM ($ Bil)	0.3
Rev Chg Q	46.8%	7.3%
Rev Chg LTM	43.0%	6.1%
Rev Chg 3Y Avg	15.4%	5.5%
PROFITABILITY	VERY POOR
Op Inc LTM ($ Bil)	0.0
CFO LTM ($ Bil)	0.0
Net Inc LTM ($ Bil)	0.0
Op Mgn LTM	6.9%	18.8%
CFO/Rev LTM	3.0%	20.4%
Net Inc Mgn	4.1%	13.1%
VALUATION	LOW
P/S	0.4	3.3
P/CFO	12.7	15.8
P/FCF	21.5	20.7
P/E	9.4	23.7
STABILITY	GOOD
Debt/Equity	0.42	0.21
Cash/Assets	0.07	0.07

AI Analysis | Feedback

Metric	Value	Date	Source
Order Backlog	205,000,000	7312025	Link

Recent
12/10/2025	Earnings Release	Rev: - EPS: -
Upcoming
3/10/2026	Earnings Release	Rev: - EPS: -

KEQU Stock

Return (1M):

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

1. Despite reporting strong top and bottom-line growth for the first quarter of fiscal year 2026 (ended July 31, 2025), Kewaunee Scientific's stock slid 19.7% following the earnings release on September 10, 2025, indicating a sharp underperformance relative to the broader market.

2. Management's outlook for fiscal year 2026 included expectations of "volatility in project delivery timelines" and "uneven results ahead," alongside an acknowledgment that strategic investments would "place pressure on near-term earnings".

3. The Corporate segment experienced a wider pre-tax loss during the first quarter of fiscal year 2026, primarily due to higher investments in corporate infrastructure and ongoing costs associated with integrating the Nu Aire subsidiary.

4. For the second quarter of fiscal year 2026 (ended October 31, 2025), Kewaunee Scientific reported a decrease in pre-tax earnings by 12.2% and a decline in net earnings, with diluted earnings per share falling to $0.82 from $1.01 in the prior year quarter.

5. Segment profitability in the second quarter of fiscal year 2026 was negatively impacted by lower manufacturing volumes within the laboratory construction portion of the business.

Stock Movement Drivers

Fundamental Drivers

The -13.1% change in KEQU stock from 9/27/2025 to 12/27/2025 was primarily driven by a -12.0% change in the company's Net Income Margin (%).

	9272025	12272025	Change
Stock Price ($)	43.74	38.00	-13.12%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	263.18	285.51	8.49%
Net Income Margin (%)	4.68%	4.11%	-12.04%
P/E Multiple	10.13	9.28	-8.48%
Shares Outstanding (Mil)	2.85	2.87	-0.53%
Cumulative Contribution			-13.13%

LTM = Last Twelve Months as of date shown

Market Drivers

9/27/2025 to 12/27/2025

	Return	Correlation
KEQU	-13.1%
Market (SPY)	4.3%	33.1%
Sector (XLY)	1.8%	32.4%

Fundamental Drivers

The -32.9% change in KEQU stock from 6/28/2025 to 12/27/2025 was primarily driven by a -48.5% change in the company's Net Income Margin (%).

	6282025	12272025	Change
Stock Price ($)	56.67	38.00	-32.95%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	220.03	285.51	29.76%
Net Income Margin (%)	7.99%	4.11%	-48.53%
P/E Multiple	9.26	9.28	0.19%
Shares Outstanding (Mil)	2.87	2.87	0.21%
Cumulative Contribution			-32.95%

LTM = Last Twelve Months as of date shown

Market Drivers

6/28/2025 to 12/27/2025

	Return	Correlation
KEQU	-32.9%
Market (SPY)	12.6%	13.6%
Sector (XLY)	11.9%	8.9%

Fundamental Drivers

The -40.4% change in KEQU stock from 12/27/2024 to 12/27/2025 was primarily driven by a -56.2% change in the company's Net Income Margin (%).

	12272024	12272025	Change
Stock Price ($)	63.81	38.00	-40.45%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	199.64	285.51	43.02%
Net Income Margin (%)	9.39%	4.11%	-56.21%
P/E Multiple	9.78	9.28	-5.11%
Shares Outstanding (Mil)	2.87	2.87	0.21%
Cumulative Contribution			-40.45%

LTM = Last Twelve Months as of date shown

Market Drivers

12/27/2024 to 12/27/2025

	Return	Correlation
KEQU	-40.4%
Market (SPY)	17.0%	34.7%
Sector (XLY)	7.0%	30.3%

Fundamental Drivers

The 145.2% change in KEQU stock from 12/28/2022 to 12/27/2025 was primarily driven by a 69.6% change in the company's P/S Multiple.

	12282022	12272025	Change
Stock Price ($)	15.50	38.00	145.16%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	195.03	285.51	46.39%
P/S Multiple	0.22	0.38	69.60%
Shares Outstanding (Mil)	2.83	2.87	-1.27%
Cumulative Contribution			145.12%

LTM = Last Twelve Months as of date shown

Market Drivers

12/28/2023 to 12/27/2025

	Return	Correlation
KEQU	30.2%
Market (SPY)	48.0%	23.4%
Sector (XLY)	37.7%	21.4%

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
KEQU Return	-7%	2%	26%	82%	113%	-39%	183%
Peers Return	16%	38%	-12%	21%	26%	16%	150%
S&P 500 Return	16%	27%	-19%	24%	23%	18%	114%
Monthly Win Rates [3]
KEQU Win Rate	33%	25%	42%	67%	67%	42%
Peers Win Rate	52%	65%	42%	68%	57%	52%
S&P 500 Win Rate	58%	75%	42%	67%	75%	73%
Max Drawdowns [4]
KEQU Max Drawdown	-47%	-8%	0%	-8%	-4%	-50%
Peers Max Drawdown	-34%	-5%	-26%	-7%	-9%	-23%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: HPQ, HPE, IBM, CSCO, AAPL.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/26/2025 (YTD)

How Low Can It Go

Unique Key	Event	KEQU	S&P 500
2022 Inflation Shock	2022 Inflation Shock
2022 Inflation Shock% Loss	% Loss	-26.3%	-25.4%
2022 Inflation Shock% Gain to Breakeven	% Gain to Breakeven	35.6%	34.1%
2022 Inflation ShockTime to Breakeven	Time to Breakeven	139 days	464 days
2020 Covid Pandemic	2020 Covid Pandemic
2020 Covid Pandemic% Loss	% Loss	-47.4%	-33.9%
2020 Covid Pandemic% Gain to Breakeven	% Gain to Breakeven	90.2%	51.3%
2020 Covid PandemicTime to Breakeven	Time to Breakeven	446 days	148 days
2018 Correction	2018 Correction
2018 Correction% Loss	% Loss	-64.6%	-19.8%
2018 Correction% Gain to Breakeven	% Gain to Breakeven	182.7%	24.7%
2018 CorrectionTime to Breakeven	Time to Breakeven	1,602 days	120 days
2008 Global Financial Crisis	2008 Global Financial Crisis
2008 Global Financial Crisis% Loss	% Loss	-67.7%	-56.8%
2008 Global Financial Crisis% Gain to Breakeven	% Gain to Breakeven	209.5%	131.3%
2008 Global Financial CrisisTime to Breakeven	Time to Breakeven	2,797 days	1,480 days

Compare to HPQ, HPE, IBM, CSCO, AAPL

In The Past

Kewaunee Scientific's stock fell -26.3% during the 2022 Inflation Shock from a high on 8/25/2022. A -26.3% loss requires a 35.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Kewaunee Scientific (KEQU)

Business Description Analogies Products Customers Suppliers Management Key Risks Emerging Threats Market Size Revenue Drivers Capital Allocation

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates in two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, commissioned agents, and a national distributor, as well as through competitive bids submitted by the company and its subsidiaries in Singapore, India, and China. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.

AI Analysis | Feedback

Here are 1-2 brief analogies for Kewaunee Scientific (KEQU):

Steelcase for scientific laboratories.
Herman Miller for research and healthcare facilities.

AI Analysis | Feedback

Laboratory Casework: Steel, wood, and laminate cabinets, benches, and tables designed for scientific and educational laboratory environments.
Fume Hoods: Safety enclosures that protect laboratory personnel by containing and exhausting hazardous fumes and vapors.
Laboratory Worksurfaces and Fixtures: Durable countertops and integrated plumbing, electrical, and gas fittings essential for laboratory operations.
Specialty Laboratory Products: A range of specialized items including safety cabinets, drying racks, and emergency showers for laboratory safety and functionality.

AI Analysis | Feedback

Kewaunee Scientific (KEQU) primarily sells its laboratory furniture, fume hoods, and related products to other companies and institutions (B2B), rather than directly to individuals. The company's customer base is diverse, spanning various industries and types of organizations that require specialized laboratory environments. Kewaunee Scientific does not disclose specific individual companies that represent a significant concentration of its revenue. Instead, it describes its major customers by the industries and types of institutions they serve. Therefore, the major customer categories served by Kewaunee Scientific include:

Pharmaceutical companies
Biotechnology companies
Chemical companies
Industrial companies
Education institutions (e.g., universities, colleges, research institutes)
Healthcare institutions (e.g., hospitals, medical research centers)
Government agencies (e.g., federal, state, and local research facilities)

No specific customer company names or their symbols can be provided, as Kewaunee Scientific's public filings and corporate information do not identify individual customers that constitute a major portion of their sales, but rather describe the broad categories of institutions and companies they serve.

AI Analysis | Feedback

null

AI Analysis | Feedback

Thomas D. Hull III, President, Chief Executive Officer

Thomas D. Hull III was elected President and Chief Executive Officer of Kewaunee Scientific on March 11, 2019. He initially joined the company as Vice President of Finance and Chief Financial Officer on November 1, 2015, at which time he was also elected Secretary and Treasurer. Prior to his tenure at Kewaunee, Mr. Hull held various management positions with Ernst & Young in Pittsburgh, Pennsylvania, from 1998 through 2011. Most recently, he served as the Vice President of Finance, Accounting, and Information Technology with ATI Specialty Materials in Charlotte, North Carolina.

Donald T. Gardner III, Vice President, Finance and Chief Financial Officer

Donald T. Gardner III joined Kewaunee Scientific as Vice President of Finance and Chief Financial Officer on April 29, 2019, simultaneously being elected Secretary and Treasurer of the Corporation. Before joining Kewaunee, he was the Vice President, Financial Planning & Analysis of Victra, which is a portfolio company backed by the private equity firm Lone Star Funds. Prior to Victra, he served as Chief Financial Officer of Component Sourcing International, another company that was a portfolio company of Argosy private equity. This demonstrates a pattern of managing companies backed by private equity firms.

Douglas J. Batdorff, Vice President, Manufacturing Operations

Douglas J. Batdorff joined Kewaunee in June 2020 as Vice President of Manufacturing Operations. He brings significant experience in directing manufacturing operations, with a focus on improving business performance and maximizing growth and profitability. His previous experience includes seven years with General Motors, thirteen years with Steelcase, and one year with Legacy Cabinets.

B. Sathyamurthy, Vice President, Kewaunee Scientific Corporation Singapore Pte. Ltd., Managing Director of International Operations

B. Sathyamurthy was elected Vice President of Kewaunee Scientific Corporation Singapore Pte. Ltd., the holding company for Kewaunee's subsidiaries in India, Singapore, and China, in September 2014. He has served as Managing Director of International Operations, overseeing all sales and operations in Asia, as well as sales efforts in the Middle East, since September 2013. Mr. Sathyamurthy joined the Kewaunee organization in 2000 as General Manager of India Operations and Kewaunee Labway India Pvt. Ltd., and was later promoted to Managing Director of Kewaunee Labway India Pvt. Ltd. and Kewaunee Scientific Corporation India Pvt. Ltd.

Mandar M. Ranade, Vice President, Information Technology and Engineering

Mandar M. Ranade joined Kewaunee in December 2019 as Vice President of Information Technology. He possesses significant experience within the laboratory furniture and infrastructure industry, as well as with companies undergoing similar technology modernization programs. Before his role at Kewaunee, Mr. Ranade held senior IT leadership positions with TCS-GE Healthcare, Thermo Fisher -Hamilton Laboratory Furniture division, IMS Health, AdvocateAurora Healthcare, and most recently as Division IT Leader for Fairbanks Morse, a division of Enpro Industries.

AI Analysis | Feedback

The key risks to Kewaunee Scientific (KEQU) primarily revolve around the inherent volatility of its core markets, challenges within its manufacturing and supply chain, and broader competitive and economic pressures.

Volatility in the laboratory and healthcare building construction industry: Kewaunee Scientific's principal markets are highly susceptible to fluctuations in the laboratory and healthcare building construction industry. This sector is subject to significant volatility due to various external factors outside the company's control. A decline in construction activity or a reduction in demand for Kewaunee Scientific's products could materially and adversely affect its business and financial condition.
Manufacturing and supply chain risks: The company faces numerous manufacturing and supply chain risks. A significant concern is its reliance on sole or limited sources of supply for certain materials, components, and services. This dependence could lead to production interruptions, delays, and inefficiencies, ultimately impacting the company's ability to deliver products and meet customer demands.
Competitive and general economic conditions: Kewaunee Scientific is exposed to risks associated with competitive and general economic conditions. These include disruptions stemming from government mandates, both domestically and internationally, as well as constraints and disruptions from suppliers. Changes in overall customer demands, shifts in the legal and regulatory environment, and fluctuations in raw material and commodity costs also pose significant risks to the business.

AI Analysis | Feedback

null

AI Analysis | Feedback

Kewaunee Scientific's main products and their addressable market sizes are as follows:

Laboratory Furniture and Casework: The global laboratory furniture market was valued at approximately USD 2.00 billion in 2025 and is projected to reach USD 3.18 billion by 2035, growing at a compound annual growth rate (CAGR) of 4.30% during the forecast period. Another report estimates the global laboratory furniture market at US$ 1.14 billion in 2024, forecast to increase to US$ 2.13 billion by 2034, expanding at a CAGR of 6.4%. The global market for lab casework was valued at US$ 1,236 million in 2024 and is projected to reach US$ 1,536 million by 2031, with a CAGR of 3.2%. For North America, the laboratory workstation & storage furniture market size was estimated at USD 1.33 billion in 2023 and is expected to grow at a CAGR of 8.3% from 2024 to 2030, reaching USD 2.30 billion by 2030. The U.S. segment of this market was estimated at USD 1.12 billion in 2023.
Fume Hoods: The global fume hood market size was valued at USD 804.27 million in 2024, growing to USD 872.12 million in 2025, with a projected CAGR of 8.33% to reach USD 1.52 billion by 2032. Other estimates place the global fume hood market at approximately USD 1.5 billion in 2024, anticipated to reach around USD 2.8 billion by 2033, reflecting a CAGR of 7.2% from 2025 to 2033. Another source indicates the global fume hood market was USD 0.64 billion in 2024 and is expected to reach USD 0.85 billion by 2033, exhibiting a CAGR of 3.2%.
Biological Safety Cabinets: The global biological safety cabinet market size was valued at USD 211.04 million in 2023 and is expected to grow at a CAGR of 7.62% from 2024 to 2030, reaching USD 352.41 million by 2030. Another report states the global biological safety cabinets market was worth USD 189.21 million in 2024 and is predicted to grow at a CAGR of 8.24% from 2025 to 2033, reaching USD 386.85 million by 2033. Another source valued the global market at USD 318.4 million in 2024, projected to grow to USD 468.5 million by 2032, with a CAGR of 5.1%.

AI Analysis | Feedback

Here are 3-5 expected drivers of future revenue growth for Kewaunee Scientific (KEQU) over the next 2-3 years:

Acquisition of Nu Aire: The recent acquisition of Nu Aire is a significant driver, expanding Kewaunee Scientific's product portfolio to include biological safety cabinets, CO2 incubators, and ultralow freezers. This acquisition also broadens Kewaunee's market reach, particularly in regions where it previously lacked distribution partners, and is expected to contribute to increased domestic sales.
Expansion into International Markets: Kewaunee Scientific is strategically focused on accelerating growth in international markets, including the Middle East, North and Sub-Saharan Africa, and India. The establishment of Kewaunee Scientific Saudia Co. supports this expansion, indicating a long-term growth strategy in these regions.
Growth in Life Sciences, Healthcare, and Education Sectors: The company serves industries that are experiencing ongoing investment in research and development, such as life sciences, healthcare, and education. This sustained investment globally is expected to drive demand for Kewaunee's laboratory furniture and technical products.
Strong Order Backlog: Kewaunee Scientific maintains a substantial order backlog, which represents future revenue. As of July 31, 2025, the company reported an order backlog of $205.0 million, indicating a consistent demand for its products and services.

AI Analysis | Feedback

Share Repurchases

Kewaunee Scientific's Board of Directors authorized the repurchase of up to an additional 100,000 shares of common stock on March 12, 2025, under an existing program.
As of March 12, 2025, including the new authorization, a total of 111,176 shares were authorized for repurchase.
The company paused share repurchases between October 2, 2023, and April 9, 2024, to prioritize the acquisition of Nu Aire, Inc., and resumed repurchases on February 28, 2025.

Share Issuance

The number of shares outstanding for Kewaunee Scientific has remained relatively stable, around 2.76 million to 2.87 million, from fiscal year 2020 to fiscal year 2025, indicating minimal significant share issuance.

Outbound Investments

Kewaunee Scientific completed the acquisition of Nu Aire, Inc. on November 1, 2024.
This acquisition was a strategic move to combine two market leaders with complementary strengths in laboratory equipment and biosafety solutions.
Cash acquisitions, primarily related to the Nu Aire acquisition, amounted to approximately $28.74 million for the fiscal year ending April 30, 2025, and the trailing twelve months ending July 31, 2025.

Capital Expenditures

Capital expenditures were approximately $2.17 million for fiscal year 2025 and $4.37 million for fiscal year 2024.
For fiscal year 2026, capital expenditures are anticipated to be around $7.0 million.
These projected fiscal year 2026 expenditures are expected to be funded primarily by operating activities, with supplemental borrowings from the revolving credit facility as needed.

Better Bets than Kewaunee Scientific (KEQU)

INDUSTRY: Household Appliances

Higher Rev Chg LTM (Value for KEQU: 43.0%)

XWIN (70.4%)

XMax

Higher Op Mgn LTM (Value for KEQU: 6.9%)

SN (12.8%)

SharkNinja

HELE (8.9%)

Helen Of Troy

FLXS (7.6%)

Flexsteel Industries

HLMN (7.2%)

Hillman Solutions

Higher CFO/Rev LTM (Value for KEQU: 3.0%)

SN (8.8%)

SharkNinja

FLXS (8.6%)

Flexsteel Industries

HLMN (7.6%)

Hillman Solutions

HELE (5.0%)

Helen Of Troy

BSET (3.7%)

Bassett Furniture Industries

Higher FCF/Rev LTM (Value for KEQU: 1.8%)

FLXS (7.7%)

Flexsteel Industries

SN (6.4%)

SharkNinja

HELE (2.8%)

Helen Of Troy

HLMN (2.7%)

Hillman Solutions

HBB (2.1%)

Hamilton Beach Brands

Higher Total Yield (Value for KEQU: 10.8%)

HBB (14.6%)

Hamilton Beach Brands

FLXS (11.2%)

Flexsteel Industries

SECTOR: Consumer Discretionary

Higher Rev Chg 3Y Avg | Lower P/S (Values for KEQU: 15.4% | 0.4x)

KLC (16.7% | 0.2x)

KinderCare Learning Companies

FLL (21.1% | 0.3x)

Full House Resorts

STKS (40.4% | 0.1x)

One Hospitality

LIVE (17.0% | 0.1x)

Live Ventures

WPRT (17.9% | 0.1x)

Westport Fuel Systems

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for KEQU: 15.4% | 5.5x)

GAMB (33.6% | 5.2x)

Gambling.com

STKS (40.4% | 1.2x)

One Hospitality

LIVE (17.0% | 2.9x)

Live Ventures

Higher Rev Chg LTM (Value for KEQU: 43.0%)

PRSU (259.8%)

Pursuit Attractions and Hospitality

SBET (239.0%)

SharpLink Gaming

STKS (51.6%)

One Hospitality

LCID (45.9%)

Lucid

CVNA (45.5%)

Carvana

Higher Rev Chg 3Y Avg (Value for KEQU: 15.4%)

LVS (51.6%)

Las Vegas Sands

MELI (39.5%)

MercadoLibre

RCL (37.7%)

Royal Caribbean

DASH (27.8%)

DoorDash

BKNG (17.8%)

Booking

Higher Op Mgn LTM (Value for KEQU: 6.9%)

MCD (46.1%)

McDonald's

BKNG (34.5%)

Booking

HD (13.0%)

Home Depot

AMZN (11.4%)

Amazon.com

TJX (11.3%)

TJX Companies

Higher CFO/Rev LTM (Value for KEQU: 3.0%)

MCD (39.9%)

McDonald's

BKNG (33.2%)

Booking

AMZN (18.1%)

Amazon.com

TSLA (16.5%)

Tesla

HD (10.6%)

Home Depot

Higher FCF/Rev LTM (Value for KEQU: 1.8%)

BKNG (31.9%)

Booking

MCD (28.1%)

McDonald's

HD (8.4%)

Home Depot

TSLA (7.1%)

Tesla

AMZN (2.0%)

Amazon.com

Higher Total Yield (Value for KEQU: 10.8%)

F (12.3%)

Ford Motor

LEN (12.0%)

Lennar

PHM (12.0%)

PulteGroup

LAD (11.0%)

Lithia Motors

PAG (10.9%)

Penske Automotive

All Other Sectors

Higher Rev Chg 3Y Avg | Lower P/S (Values for KEQU: 15.4% | 0.4x)

SNEX (29.6% | 0.0x)

StoneX

STNE (21.3% | 0.3x)

StoneCo

OSCR (46.4% | 0.3x)

Oscar Health

CNXC (17.9% | 0.3x)

Concentrix

FWRD (22.0% | 0.3x)

Forward Air

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for KEQU: 15.4% | 5.5x)

IBKR (48.1% | 3.5x)

Interactive Brokers

PR (48.7% | 4.8x)

Permian Resources

BIPC (30.2% | 2.5x)

Brookfield Infrastructure

SNEX (29.6% | 2.6x)

StoneX

CALM (31.8% | 2.5x)

Cal-Maine Foods

Higher Rev Chg LTM (Value for KEQU: 43.0%)

APP (86.4%)

AppLovin

NVDA (65.2%)

NVIDIA

APH (47.4%)

Amphenol

PLTR (47.2%)

Palantir Technologies

MU (45.4%)

Micron Technology

Higher Rev Chg 3Y Avg (Value for KEQU: 15.4%)

NVDA (91.6%)

NVIDIA

AVGO (25.2%)

Broadcom

LLY (23.4%)

Eli Lilly

BRK-B (19.8%)

Berkshire Hathaway

META (17.3%)

Meta Platforms

Higher Op Mgn LTM (Value for KEQU: 6.9%)

NVDA (58.8%)

NVIDIA

MSFT (46.3%)

Microsoft

META (43.2%)

Meta Platforms

GOOGL (32.2%)

Alphabet

AAPL (31.9%)

Apple

Higher CFO/Rev LTM (Value for KEQU: 3.0%)

META (56.8%)

Meta Platforms

MSFT (50.0%)

Microsoft

NVDA (44.4%)

NVIDIA

GOOGL (39.3%)

Alphabet

AAPL (26.6%)

Apple

Higher FCF/Rev LTM (Value for KEQU: 1.8%)

NVDA (41.3%)

NVIDIA

MSFT (26.6%)

Microsoft

META (23.7%)

Meta Platforms

AAPL (23.5%)

Apple

GOOGL (19.1%)

Alphabet

Higher Total Yield (Value for KEQU: 10.8%)

VZ (18.3%)

Verizon Communications

PFE (13.7%)

Pfizer

TD (12.8%)

Toronto-Dominion Bank

T (12.6%)

AT&T

COP (11.1%)

ConocoPhillips

		Best Bets In Consumer Discretionary Sector
	KEQU	ABNB	BKNG	DUOL	MCD	ETSY	LOPE	ALSN	GRMN	CROX	WH
What You Pay
P/E	9.3	31.8	34.9	21.6	26.3	30.4	22.1	12.1	25.2	21.6	17.3
P/EBIT	5.4	30.9	21.0	78.7	18.1	13.4	14.7	8.9	22.2	18.8	10.2
What You Get
Rev Chg Q	46.8%	9.7%	12.7%	41.1%	3.0%	2.4%	9.6%	-15.9%	11.7%	3.4%	-3.5%
Rev Chg LTM	43.0%	10.2%	13.0%	39.9%	1.2%	2.0%	7.0%	-4.2%	16.6%	2.0%	3.4%
Rev Chg 3Y Avg	15.4%	14.2%	17.8%	41.7%	4.2%	4.9%	6.5%	4.6%	12.2%	14.5%	-2.5%
FCF/Rev 3Y Avg	3.2%	40.2%	35.6%	30.3%	27.4%	23.8%	21.8%	21.0%	20.5%	19.8%	19.0%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 14%, alpha of 2.9%, and sharpe of 0.61

Latest Trefis Analyses

	Title	Topic
0	DASHBOARDS
1	Kewaunee Scientific Earnings Notes
2	How Low Can Kewaunee Scientific Stock Really Go?	Return

	Title
0	ARTICLES

Trade Ideas

Select ideas related to KEQU. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
BBWI_11302025_Dip_Buyer_1M_Insider_Buying_GTE_1Mil_EBITp+DE	11302025	BBWI	Bath & Body Works	Dip Buy	DB \| Insider Buys \| Low D/EDip Buy with Strong Insider Buying Buying dips for companies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap	13.7%	13.7%	0.0%
HRB_11262025_Dip_Buyer_FCFYield	11262025	HRB	H&R Block	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	6.0%	6.0%	-0.1%
LRN_11262025_Dip_Buyer_FCFYield	11262025	LRN	Stride	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	3.8%	3.8%	-4.4%
ABNB_11212025_Dip_Buyer_FCFYield	11212025	ABNB	Airbnb	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	19.7%	19.7%	0.0%
MTN_11212025_Dip_Buyer_FCFYield	11212025	MTN	Vail Resorts	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	2.3%	2.3%	-1.6%

Recent Active Movers

Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
ZETA	Zeta Global	4.6	8.3%	15.1%
SGML	Sigma Lithium	1.6	7.3%	29.2%
USAS	Americas Gold And Silver	1.6	6.6%	557.6%
CPNG	Coupang	44.2	6.4%	10.4%
LION	Lionsgate Studios	2.7	4.6%	-69.9%
BBW	Build-A-Bear Workshop	0.8	4.4%	37.8%
XRAY	Dentsply Sirona	2.3	4.2%	-36.3%
BLMN	Bloomin Brands	0.6	3.8%	-41.2%
FUN	Six Flags Entertainment	1.5	3.8%	-69.1%
SVM	Silvercorp Metals	1.9	3.6%	198.0%

Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
FLY	Firefly Aerospace	3.3	-13.7%	-61.3%
TMC	TMC The Metals	2.5	-10.5%	508.9%
ORGO	Organogenesis	0.7	-10.1%	64.8%
AAOI	Applied Optoelectronics	2.4	-9.3%	0.8%
BKSY	BlackSky Technology	0.7	-9.0%	79.0%
LUNR	Intuitive Machines	1.8	-8.7%	-16.0%
RCAT	Red Cat	0.8	-8.7%	-35.4%
RGTI	Rigetti Computing	6.7	-8.7%	46.7%
RDW	Redwire	1.0	-8.6%	-56.6%
RKLB	Rocket Lab	36.4	-8.5%	177.4%

Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
OMER	Omeros	0.9	71.5%	59.0%
RZLT	Rezolute	0.3	44.3%	-45.5%
DVAX	Dynavax Technologies	1.8	41.5%	20.4%
LUNR	Intuitive Machines	1.8	40.6%	-16.0%
UAMY	United States Antimony	0.7	39.0%	252.5%
FOLD	Amicus Therapeutics	4.4	30.9%	51.3%
ADEA	Adeia	1.9	30.3%	23.0%
HUT	Hut 8	5.2	28.6%	142.3%
AAOI	Applied Optoelectronics	2.4	27.1%	0.8%
SGML	Sigma Lithium	1.6	24.9%	29.2%

Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
TPL	Texas Pacific Land	6.6	-67.9%	-21.5%
LW	Lamb Weston	5.9	-29.0%	-35.3%
TLRY	Tilray Brands	10.2	-22.2%	-27.8%
TDUP	ThredUp	0.8	-18.2%	348.2%
LAB	Standard BioTools	0.5	-16.9%	-21.1%
OLMA	Olema Pharmaceuticals	2.2	-14.9%	349.9%
EVEX	Eve	1.4	-12.0%	-21.9%
IRON	Disc Medicine	2.8	-11.2%	26.7%
AVO	Mission Produce	0.8	-11.1%	-18.8%
CABO	Cable One	0.7	-10.6%	-67.4%

Top Gainers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
TLRY	Tilray Brands	10.2	876.4%	-27.8%
HPP	Hudson Pacific Properties	4.7	452.7%	-51.0%
WVE	WAVE Life Sciences	2.9	139.2%	43.7%
TE	T1 Energy	1.1	106.7%	400.0%
VERA	Vera Therapeutics	3.4	82.1%	26.7%
OMER	Omeros	0.9	66.2%	59.0%
RKLB	Rocket Lab	36.4	65.8%	177.4%
PL	Planet Labs PBC	5.9	65.0%	379.2%
AAOI	Applied Optoelectronics	2.4	63.5%	0.8%
LUNR	Intuitive Machines	1.8	62.4%	-16.0%

Top Losers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
RZLT	Rezolute	0.3	-72.0%	-45.5%
JANX	Janux Therapeutics	0.9	-59.0%	-73.4%
FRMI	Fermi	5.3	-46.0%	-76.6%
LENZ	LENZ Therapeutics	0.5	-43.5%	-41.6%
GOGO	Gogo	0.6	-35.3%	-43.0%
HPK	HighPeak Energy	0.5	-33.9%	-70.4%
PACB	Pacific Biosciences of California	0.5	-32.7%	-3.3%
LDI	loanDepot	0.4	-29.6%	3.9%
ORIC	ORIC Pharmaceuticals	0.6	-29.0%	2.2%
LW	Lamb Weston	5.9	-28.6%	-35.3%

Peer Comparisons for Kewaunee Scientific

Peers to compare with:

Financials

	KEQU	HPQ	HPE	IBM	CSCO	AAPL	Median
Name	Kewaunee.	HP	Hewlett .	Internat.	Cisco Sy.	Apple
Mkt Price	38.00	23.26	24.49	305.09	78.16	273.40	58.08
Mkt Cap	0.1	21.9	32.6	284.9	309.2	4,074.4	158.8
Rev LTM	286	55,295	34,296	65,402	57,696	408,625	56,496
Op Inc LTM	20	3,624	1,644	11,544	12,991	130,214	7,584
FCF LTM	5	2,800	627	11,854	12,733	96,184	7,327
FCF 3Y Avg	7	2,978	1,400	11,753	13,879	100,503	7,366
CFO LTM	9	3,697	2,919	13,483	13,744	108,565	8,590
CFO 3Y Avg	11	3,672	3,896	13,498	14,736	111,559	8,697

Growth & Margins

	KEQU	HPQ	HPE	IBM	CSCO	AAPL	Median
Name	Kewaunee.	HP	Hewlett .	Internat.	Cisco Sy.	Apple
Rev Chg LTM	43.0%	3.2%	13.8%	4.5%	8.9%	6.0%	7.4%
Rev Chg 3Y Avg	15.4%	-3.9%	6.5%	2.6%	3.7%	1.8%	3.2%
Rev Chg Q	46.8%	4.2%	14.4%	9.1%	7.5%	9.6%	9.4%
QoQ Delta Rev Chg LTM	8.5%	1.1%	3.7%	2.1%	1.8%	2.1%	2.1%
Op Mgn LTM	6.9%	6.6%	4.8%	17.7%	22.5%	31.9%	12.3%
Op Mgn 3Y Avg	7.2%	7.4%	7.2%	16.4%	24.2%	30.8%	11.9%
QoQ Delta Op Mgn LTM	-0.7%	-0.2%	-1.4%	0.6%	0.4%	0.1%	-0.1%
CFO/Rev LTM	3.0%	6.7%	8.5%	20.6%	23.8%	26.6%	14.6%
CFO/Rev 3Y Avg	5.0%	6.8%	12.7%	21.4%	26.1%	28.4%	17.1%
FCF/Rev LTM	1.8%	5.1%	1.8%	18.1%	22.1%	23.5%	11.6%
FCF/Rev 3Y Avg	3.2%	5.5%	4.6%	18.6%	24.6%	25.6%	12.1%

Valuation

	KEQU	HPQ	HPE	IBM	CSCO	AAPL	Median
Name	Kewaunee.	HP	Hewlett .	Internat.	Cisco Sy.	Apple
Mkt Cap	0.1	21.9	32.6	284.9	309.2	4,074.4	158.8
P/S	0.4	0.4	1.0	4.4	5.4	10.0	2.7
P/EBIT	5.4	6.8	19.9	25.1	22.5	31.3	21.2
P/E	9.3	8.6	572.7	36.0	29.9	41.0	33.0
P/CFO	12.6	5.9	11.2	21.1	22.5	37.5	16.8
Total Yield	10.8%	14.1%	2.3%	5.0%	5.4%	2.8%	5.2%
Dividend Yield	0.0%	2.5%	2.1%	2.2%	2.1%	0.4%	2.1%
FCF Yield 3Y Avg	6.6%	10.6%	5.5%	6.4%	6.0%	3.1%	6.2%
D/E	0.4	0.5	0.7	0.2	0.1	0.0	0.3
Net D/E	0.3	0.3	0.6	0.2	0.0	0.0	0.2

Returns

	KEQU	HPQ	HPE	IBM	CSCO	AAPL	Median
Name	Kewaunee.	HP	Hewlett .	Internat.	Cisco Sy.	Apple
1M Rtn	-0.9%	-1.8%	14.4%	0.6%	2.7%	-1.5%	-0.1%
3M Rtn	-13.1%	-11.9%	2.7%	7.9%	17.0%	7.1%	4.9%
6M Rtn	-32.9%	-4.0%	34.5%	6.6%	15.2%	36.3%	10.9%
12M Rtn	-40.4%	-27.0%	16.2%	40.5%	34.5%	7.5%	11.8%
3Y Rtn	145.2%	-1.9%	71.1%	143.1%	81.3%	120.2%	100.7%
1M Excs Rtn	-4.3%	-5.6%	12.9%	-2.2%	-0.0%	-3.7%	-3.0%
3M Excs Rtn	-17.4%	-16.2%	-1.7%	3.6%	12.7%	2.8%	0.6%
6M Excs Rtn	-45.2%	-16.3%	22.3%	-5.7%	3.0%	24.0%	-1.3%
12M Excs Rtn	-45.2%	-42.9%	-0.7%	25.0%	19.9%	-8.4%	-4.6%
3Y Excs Rtn	58.2%	-83.5%	-11.2%	59.6%	-1.2%	28.4%	13.6%

FDIC Bank Data

Bank Capital

null

Bank Deposits

null

Bank Assets

null

Bank Loans

null

FDA Approved Drugs Data

Expand for Morenull

Financials

Annual
Quarterly

$ Mil \| FY: 4/30	LTM	2025	2024	2023	2022	2021	2020
Period End	10/31/2025	4/30/2025	4/30/2024	4/30/2023	4/30/2022	4/30/2021	4/30/2020
Filing Date	12/12/2025	7/2/2025	6/28/2024	6/30/2023	7/1/2022	7/15/2021	7/27/2020
Key Financials
Total Revenue	286	240	204	219	169	147	148
EBITDA	26	23	18	9	1	0	0
Operating Income	20	18	18	5	-3	-1	-2
Net Income	12	11	19	1	-6	-4	-5
EPS	4.10	3.98	6.51	0.26	-2.20	-1.33	-1.70
Growth Rates
Total Revenue Growth	43.0%	18.0%	-7.2%	30.0%	14.5%	-0.0%	0.7%
EBITDA Growth	61.6%	26.1%	98.3%	893.3%	99.6%	63.3%	-94.5%
Operating Income Growth	20.1%	-2.9%	240.8%	305.7%	-98.2%	43.9%	-211.0%
Net Income Growth	-37.4%	-39.2%	2441.1%	112.0%	-66.8%	21.7%	-406.5%
Margins
EBITDA Margin	9.3%	9.5%	8.9%	4.1%	0.5%	0.3%	0.2%
Operating Income Margin	6.9%	7.4%	9.0%	2.4%	-1.5%	-0.9%	-1.6%
Net Income Margin	4.1%	4.7%	9.2%	0.3%	-3.6%	-2.5%	-3.2%
Cash & Debt
Total Cash	13	15	23	8	4	5	4
Total Debt	47	50	11	13	9	16	14
Net Debt / (Cash)	34	35	-12	5	5	11	10
Cash Flows
Net Cash from Operations	9	15	20	-4	-8	1	4
Free Cash from Operations	5	13	15	-8	-10	-1	2
Returns to Shareholders
Dividends	0	-0	-0	-0	-0	-0	1
Share Repurchases	2	2	2	-0	-0	-0	-0

$ Mil \| FY: 4/30	2026Q2	2026Q1	2025Q4	2025Q3	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3
Period End	10/31/2025	7/31/2025	4/30/2025	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023
Filing Date	12/12/2025	9/12/2025	7/2/2025	3/14/2025	12/13/2024	9/13/2024	6/28/2024	3/8/2024	12/8/2023	9/1/2023	6/30/2023	3/10/2023
Key Financials Quarterly
Total Revenue	70	71	77	67	48	48	57	47	50	50	54	61
Ebitda	6	7	10	4	5	4	3	5	6	5	4	3
Operating Income	4	5	8	2	4	3	6	4	5	4	3	2
Net Income	2	3	5	1	3	2	11	3	3	2	1	1
EPS	0.85	1.08	1.70	0.47	1.05	0.77	3.86	0.87	0.94	0.87	0.36	0.26
Key Financials TTM
Total Revenue TTM	286	263	240	220	200	202	204	201	215	219	219	215
Ebitda TTM	26	26	23	16	16	17	18	19	17	13	9	9
Operating Income TTM	20	20	18	15	16	17	18	15	14	10	5	5
Net Income TTM	12	12	11	18	19	18	19	9	7	4	1	-1
Growth Rates Quarterly
Total Revenue Growth	46.8%	46.9%	36.1%	43.6%	-5.3%	-2.9%	5.0%	-23.1%	-7.6%	-0.6%	8.6%	49.7%
EBITDA Growth	17.7%	75.6%	259.1%	-16.2%	-13.5%	-18.5%	-23.3%	48.0%	290.3%	493.0%	10.2%	9812.1%
Operating Income Growth	-7.4%	86.8%	52.9%	-40.9%	-12.5%	-32.4%	101.8%	66.5%	578.6%	1000.2%	22.9%	363.4%
Net Income Growth	-18.7%	41.0%	-56.0%	-46.3%	10.1%	-11.4%	997.1%	248.7%	1224.3%	431.2%	377.6%	154.8%
Margins Quarterly
EBITDA Margin	8.7%	9.2%	12.8%	5.9%	10.8%	7.7%	4.9%	10.1%	11.9%	9.1%	6.7%	5.3%
Operating Income Margin	5.9%	6.8%	11.0%	3.3%	9.3%	5.3%	9.8%	8.1%	10.1%	7.6%	5.1%	3.8%
Net Income Margin	3.5%	4.3%	6.3%	2.0%	6.3%	4.5%	19.4%	5.4%	5.4%	5.0%	1.9%	1.2%
Cash & Debt
Total Cash	13	19	15	9	26	24	23	21	14	13	8	13
Total Debt	47	48	50	52	8	11	11	11	15	14	13	15
Net Debt / (Cash)	34	29	35	43	-18	-13	-12	-10	1	1	5	2
Cash Flows Quarterly
FCF from Operations	-4	6	9	-2	8	-1	1	10	1	8	-0	-3
Cash Flows TTM
FCF from Operations TTM	9	21	15	7	18	11	20	18	6	1	-4	-10
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-0	-0	2	-0	-0	-0	1	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	33.7%	51.0%	63.4%	18.9%	-	-	-	-	133.4%	120.9%	38.6%	49.0%
Return on Invested Capital (ROIC) TTM
ROIC TTM	41.8%	50.5%	37.5%	31.2%	-	-	-	-	93.5%	57.5%	12.1%	48.8%

Segment Financials

Revenue by Segment

$ Mil	2025	2024	2023	2022	2021
Single Segment	204	219	169	147	148
Total	204	219	169	147	148

Price Behavior

Price Behavior

Market Price	$38.00
Market Cap ($ Bil)	0.1
First Trading Date	02/25/1992
Distance from 52W High	-45.5%
	50 Days	200 Days
DMA Price	$40.38	$44.06
DMA Trend	down	down
Distance from DMA	-5.9%	-13.8%
	3M	1YR
Volatility	32.4%	63.8%
Downside Capture	98.55	141.70
Upside Capture	10.90	67.97
Correlation (SPY)	32.5%	34.5%

KEQU Betas & Captures as of 11/30/2025

	1M	2M	3M	6M	1Y	3Y
Beta	1.03	1.01	0.58	1.34	1.12	0.71
Up Beta	0.25	0.34	-0.50	0.86	0.98	0.57
Down Beta	2.45	1.74	1.61	1.47	1.42	0.85
Up Capture	-7%	24%	-74%	101%	84%	54%
Bmk +ve Days	13	26	39	74	142	427
Stock +ve Days	8	19	26	57	112	335
Down Capture	162%	131%	138%	157%	109%	85%
Bmk -ve Days	7	16	24	52	107	323
Stock -ve Days	12	23	37	68	135	343

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Based On 1-Year Data

		Comparison of KEQU With Other Asset Classes (Last 1Y)
	KEQU	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	-29.5%	7.5%	17.8%	72.1%	8.6%	4.4%	-8.2%
Annualized Volatility	64.9%	24.3%	19.4%	19.3%	15.2%	17.0%	35.0%
Sharpe Ratio	-0.29	0.24	0.72	2.70	0.34	0.09	-0.08
Correlation With Other Assets		31.2%	34.8%	-0.6%	12.5%	17.6%	13.8%

ETFs used for asset classes: Sector ETF = XLY, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How

Based On 5-Year Data

		Comparison of KEQU With Other Asset Classes (Last 5Y)
	KEQU	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	28.9%	9.6%	14.7%	18.7%	11.5%	4.6%	30.8%
Annualized Volatility	51.8%	23.8%	17.1%	15.5%	18.7%	18.9%	48.6%
Sharpe Ratio	0.71	0.36	0.70	0.97	0.50	0.16	0.57
Correlation With Other Assets		13.2%	16.0%	-1.1%	1.0%	6.5%	5.4%

Based On 10-Year Data

		Comparison of KEQU With Other Asset Classes (Last 10Y)
	KEQU	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	9.4%	13.2%	14.8%	15.3%	7.0%	5.3%	69.2%
Annualized Volatility	47.3%	21.9%	18.0%	14.7%	17.6%	20.8%	55.8%
Sharpe Ratio	0.37	0.55	0.71	0.86	0.32	0.22	0.90
Correlation With Other Assets		13.2%	14.0%	0.0%	3.6%	9.8%	4.0%

Short Interest

Short Interest: As Of Date	12152025
Short Interest: Shares Quantity	35,595
Short Interest: % Change Since 11302025	66.4%
Average Daily Volume	8,858
Days-to-Cover Short Interest	4.02
Basic Shares Quantity	2,866,000
Short % of Basic Shares	1.2%

Returns Analyses

	Title
0	How Low Can Kewaunee Scientific Stock Really Go?

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
12/10/2025	-4.4%	-2.8%
9/10/2025	-21.2%	-17.3%	-21.1%
6/26/2025	3.4%	6.6%	6.9%
3/12/2025	-2.0%	0.2%	-29.8%
12/11/2024	26.1%	23.8%	30.5%
9/11/2024	-3.8%	-10.4%	-24.5%
6/26/2024	10.2%	20.2%	37.9%
3/6/2024	-4.0%	-3.0%	16.6%
...
SUMMARY STATS
# Positive	11	10	11
# Negative	11	12	11
Median Positive	2.8%	4.4%	9.7%
Median Negative	-3.3%	-3.2%	-12.6%
Max Positive	29.3%	28.0%	58.7%
Max Negative	-22.3%	-26.3%	-32.7%

	Forward Returns
12/10/2025	-4.4%	-2.8%
9/10/2025	-21.2%	-17.3%	-21.1%
6/26/2025	3.4%	6.6%	6.9%
3/12/2025	-2.0%	0.2%	-29.8%
12/11/2024	26.1%	23.8%	30.5%
9/11/2024	-3.8%	-10.4%	-24.5%
6/26/2024	10.2%	20.2%	37.9%
3/6/2024	-4.0%	-3.0%	16.6%
12/6/2023	29.3%	28.0%	58.7%
6/28/2023	0.8%	-5.7%	-3.2%
3/8/2023	9.3%	3.6%	0.4%
12/8/2022	1.0%	-1.8%	-3.9%
9/8/2022	-2.3%	-3.4%	-4.1%
6/30/2022	-0.1%	2.2%	9.7%
3/10/2022	-1.3%	3.9%	2.2%
12/17/2021	0.2%	0.4%	6.1%
7/9/2021	-3.3%	-1.5%	-2.3%
3/11/2021	1.1%	-1.5%	-1.2%
12/10/2020	2.8%	4.8%	26.0%
7/22/2020	2.1%	-1.1%	7.2%
3/4/2020	-1.0%	-14.3%	-32.7%
12/16/2019	-22.3%	-26.3%	-28.8%
SUMMARY STATS
# Positive	11	10	11
# Negative	11	12	11
Median Positive	2.8%	4.4%	9.7%
Median Negative	-3.3%	-3.2%	-12.6%
Max Positive	29.3%	28.0%	58.7%
Max Negative	-22.3%	-26.3%	-32.7%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
10312025	12122025	10-Q 10/31/2025
7312025	9122025	10-Q 7/31/2025
4302025	7022025	10-K 4/30/2025
1312025	3142025	10-Q 1/31/2025
10312024	12132024	10-Q 10/31/2024
7312024	9132024	10-Q 7/31/2024
4302024	6282024	10-K 4/30/2024
1312024	3082024	10-Q 1/31/2024
10312023	12082023	10-Q 10/31/2023
7312023	9012023	10-Q 7/31/2023
4302023	6302023	10-K 4/30/2023
1312023	3102023	10-Q 1/31/2023
10312022	12092022	10-Q 10/31/2022
7312022	9092022	10-Q 7/31/2022
4302022	7012022	10-K 4/30/2022
1312022	3112022	10-Q 1/31/2022

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	Phillips Elizabeth D	VP - Human Resources	10022025	Sell	43.20	6,877	297,086	356,443	Form
1	HULL THOMAS DAVID III	President, CEO	10022025	Sell	43.09	1,000	43,090	1,668,402	Form

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Kewaunee Scientific (KEQU)

Market Price (12/28/2025): $38.45 | Market Cap: $110.2 MilSector: Consumer Discretionary | Industry: Household Appliances

Kewaunee Scientific (KEQU)

Market Price (12/28/2025): $38.45Market Cap: $110.2 MilSector: Consumer DiscretionaryIndustry: Household Appliances

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

Valuation, Metrics & Events

KEQU Stock

Why The Stock Moved

Qualitative Assessment

Stock Movement Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

About Kewaunee Scientific (KEQU)

Share Repurchases

Share Issuance

Outbound Investments

Capital Expenditures

Interactive Breakdown

Better Bets than Kewaunee Scientific (KEQU)

INDUSTRY: Household Appliances

Higher Rev Chg LTM (Value for KEQU: 43.0%)

Higher Op Mgn LTM (Value for KEQU: 6.9%)

Higher CFO/Rev LTM (Value for KEQU: 3.0%)

Higher FCF/Rev LTM (Value for KEQU: 1.8%)

Higher Total Yield (Value for KEQU: 10.8%)

SECTOR: Consumer Discretionary

Higher Rev Chg 3Y Avg | Lower P/S (Values for KEQU: 15.4% | 0.4x)

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for KEQU: 15.4% | 5.5x)

Higher Rev Chg LTM (Value for KEQU: 43.0%)

Higher Rev Chg 3Y Avg (Value for KEQU: 15.4%)

Higher Op Mgn LTM (Value for KEQU: 6.9%)

Higher CFO/Rev LTM (Value for KEQU: 3.0%)

Higher FCF/Rev LTM (Value for KEQU: 1.8%)

Higher Total Yield (Value for KEQU: 10.8%)

All Other Sectors

Higher Rev Chg 3Y Avg | Lower P/S (Values for KEQU: 15.4% | 0.4x)

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for KEQU: 15.4% | 5.5x)

Higher Rev Chg LTM (Value for KEQU: 43.0%)

Higher Rev Chg 3Y Avg (Value for KEQU: 15.4%)

Higher Op Mgn LTM (Value for KEQU: 6.9%)

Higher CFO/Rev LTM (Value for KEQU: 3.0%)

Higher FCF/Rev LTM (Value for KEQU: 1.8%)

Higher Total Yield (Value for KEQU: 10.8%)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

Top Gainers

Top Losers

Top Gainers

Top Losers

Top Gainers

Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Kewaunee Scientific

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

FDA Approved Drugs Data

Market Price (12/28/2025): $38.45 | Market Cap: $110.2 Mil
Sector: Consumer Discretionary | Industry: Household Appliances

Market Price (12/28/2025): $38.45
Market Cap: $110.2 Mil
Sector: Consumer Discretionary
Industry: Household Appliances